{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:18:16Z","timestamp":1789881496187,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T00:00:00Z","timestamp":1468972800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T00:00:00Z","timestamp":1468972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA021765"],"award-info":[{"award-number":["P30 CA021765"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuroradiology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00234-016-1724-8","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T09:14:22Z","timestamp":1469006062000},"page":"1027-1034","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Discrepant longitudinal volumetric and metabolic evolution of diffuse intrinsic Pontine gliomas during treatment: implications for current response assessment strategies"],"prefix":"10.1007","volume":"58","author":[{"given":"U.","family":"L\u00f6bel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Broniscer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Patay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,20]]},"reference":[{"key":"1724_CR1","unstructured":"CBTRUS (2010) CBTRUS. Statistical Report: Primary brain and central nervous system tumors diagnosed in the United States in 2004\u20132006"},{"key":"1724_CR2","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1002\/1097-0142(19831215)52:12<2313::AID-CNCR2820521226>3.0.CO;2-I","volume":"52","author":"AL Albright","year":"1983","unstructured":"Albright AL, Price RA, Guthkelch AN (1983) Brain stem gliomas of children. A clinicopathological study. Cancer 52:2313\u20132319","journal-title":"Cancer"},{"key":"1724_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3171\/jns.1986.64.1.0011","volume":"64","author":"F Epstein","year":"1986","unstructured":"Epstein F, McCleary EL (1986) Intrinsic brain-stem tumors of childhood: surgical indications. J Neurosurg 64:11\u201315. doi:\n                    10.3171\/jns.1986.64.1.0011","journal-title":"J Neurosurg"},{"key":"1724_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000121036","volume":"24","author":"AM Kaplan","year":"1996","unstructured":"Kaplan AM, Albright AL, Zimmerman RA et al (1996) Brainstem gliomas in children. A Children\u2019s Cancer Group review of 119 cases. Pediatr Neurosurg 24:185\u2013192","journal-title":"Pediatr Neurosurg"},{"key":"1724_CR5","first-page":"806","volume":"27","author":"SB Thakur","year":"2006","unstructured":"Thakur SB, Karimi S, Dunkel IJ et al (2006) Longitudinal MR spectroscopic imaging of pediatric diffuse pontine tumors to assess tumor aggression and progression. AJNR Am J Neuroradiol 27:806\u2013809","journal-title":"AJNR Am J Neuroradiol"},{"key":"1724_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11060-007-9473-5","volume":"86","author":"D Hargrave","year":"2008","unstructured":"Hargrave D, Chuang N, Bouffet E (2008) Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma. J Neurooncol 86:313\u2013319. doi:\n                    10.1007\/s11060-007-9473-5","journal-title":"J Neurooncol"},{"key":"1724_CR7","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00247-009-1368-5","volume":"39","author":"AK Liu","year":"2009","unstructured":"Liu AK, Brandon J, Foreman NK, Fenton LZ (2009) Conventional MRI at presentation does not predict clinical response to radiation therapy in children with diffuse pontine glioma. Pediatr Radiol 39:1317\u20131320. doi:\n                    10.1007\/s00247-009-1368-5","journal-title":"Pediatr Radiol"},{"key":"1724_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","volume":"7","author":"D Hargrave","year":"2006","unstructured":"Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7:241\u2013248. doi:\n                    10.1016\/S1470-2045(06)70615-5","journal-title":"Lancet Oncol"},{"key":"1724_CR9","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/neuonc\/nor076","volume":"13","author":"SJ Hipp","year":"2011","unstructured":"Hipp SJ, Steffen-Smith E, Hammoud D et al (2011) Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging. Neurooncol 13:904\u2013909. doi:\n                    10.1093\/neuonc\/nor076","journal-title":"Neurooncol"},{"key":"1724_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1215\/15228517-2007-042","volume":"10","author":"A Panigrahy","year":"2008","unstructured":"Panigrahy A, Nelson MD, Finlay JL et al (2008) Metabolism of diffuse intrinsic brainstem gliomas in children. Neurooncol 10:32\u201344. doi:\n                    10.1215\/15228517-2007-042","journal-title":"Neurooncol"},{"key":"1724_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11060-011-0601-x","volume":"105","author":"EA Steffen-Smith","year":"2011","unstructured":"Steffen-Smith EA, Shih JH, Hipp SJ et al (2011) Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma. J Neurooncol 105:365\u2013373. doi:\n                    10.1007\/s11060-011-0601-x","journal-title":"J Neurooncol"},{"key":"1724_CR12","doi-asserted-by":"publisher","first-page":"4762","DOI":"10.1200\/JCO.2010.30.3545","volume":"28","author":"A Broniscer","year":"2010","unstructured":"Broniscer A, Baker JN, Tagen M et al (2010) Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma. J Clin Oncol 28:4762\u20134768. doi:\n                    10.1200\/JCO.2010.30.3545","journal-title":"J Clin Oncol"},{"key":"1724_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/neuonc\/nor038","volume":"13","author":"F Yamasaki","year":"2011","unstructured":"Yamasaki F, Kurisu K, Kajiwara Y et al (2011) Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma. Neurooncol 13:791\u2013801. doi:\n                    10.1093\/neuonc\/nor038","journal-title":"Neurooncol"},{"key":"1724_CR14","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/1097-0142(197910)44:4<1256::AID-CNCR2820440415>3.0.CO;2-T","volume":"44","author":"PC Burger","year":"1979","unstructured":"Burger PC, Mahley MS, Dudka L, Vogel FS (1979) The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer 44:1256\u20131272","journal-title":"Cancer"},{"key":"1724_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1586\/ecp.11.1","volume":"4","author":"J Dietrich","year":"2011","unstructured":"Dietrich J, Rao K, Pastorino S, Kesari S (2011) Corticosteroids in brain cancer patients: benefits and pitfalls. Expert Rev Clin Pharmacol 4:233\u2013242. doi:\n                    10.1586\/ecp.11.1","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1724_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1023\/A:1006416003964","volume":"50","author":"MR Machein","year":"2000","unstructured":"Machein MR, Plate KH (2000) VEGF in brain tumors. J Neurooncol 50:109\u2013120","journal-title":"J Neurooncol"},{"key":"1724_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ana.410190411","volume":"19","author":"ET Hedley-Whyte","year":"1986","unstructured":"Hedley-Whyte ET, Hsu DW (1986) Effect of dexamethasone on blood\u2013brain barrier in the normal mouse. Ann Neurol 19:373\u2013377. doi:\n                    10.1002\/ana.410190411","journal-title":"Ann Neurol"},{"key":"1724_CR18","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1172\/JCI118927","volume":"98","author":"JD Heiss","year":"1996","unstructured":"Heiss JD, Papavassiliou E, Merrill MJ et al (1996) Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor. J Clin Invest 98:1400\u20131408. doi:\n                    10.1172\/JCI118927","journal-title":"J Clin Invest"},{"key":"1724_CR19","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.neuroscience.2004.05.044","volume":"129","author":"MC Papadopoulos","year":"2004","unstructured":"Papadopoulos MC, Saadoun S, Binder DK et al (2004) Molecular mechanisms of brain tumor edema. Neuroscience 129:1011\u20131020. doi:\n                    10.1016\/j.neuroscience.2004.05.044","journal-title":"Neuroscience"},{"key":"1724_CR20","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3174\/ajnr.A3421","volume":"34","author":"J Sedlacik","year":"2013","unstructured":"Sedlacik J, Winchell A, Kocak M et al (2013) MR imaging assessment of tumor perfusion and 3D segmented volume at baseline, during treatment, and at tumor progression in children with newly diagnosed diffuse intrinsic pontine glioma. AJNR Am J Neuroradiol 34:1450\u20131455. doi:\n                    10.3174\/ajnr.A3421","journal-title":"AJNR Am J Neuroradiol"},{"key":"1724_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/neuonc\/noq200","volume":"13","author":"TY Poussaint","year":"2011","unstructured":"Poussaint TY, Kocak M, Vajapeyam S et al (2011) MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). Neuro-Oncol 13:417\u2013427. doi:\n                    10.1093\/neuonc\/noq200","journal-title":"Neuro-Oncol"},{"key":"1724_CR22","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.neuroimage.2004.06.022","volume":"23","author":"A Stadlbauer","year":"2004","unstructured":"Stadlbauer A, Moser E, Gruber S et al (2004) Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas. NeuroImage 23:454\u2013461. doi:\n                    10.1016\/j.neuroimage.2004.06.022","journal-title":"NeuroImage"},{"key":"1724_CR23","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","volume":"8","author":"DR Macdonald","year":"1990","unstructured":"Macdonald DR, Cascino TL, Schold SC, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277\u20131280","journal-title":"J Clin Oncol"},{"key":"1724_CR24","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963\u20131972. doi:\n                    10.1200\/JCO.2009.26.3541","journal-title":"J Clin Oncol"},{"key":"1724_CR25","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/pbc.24562","volume":"60","author":"KE Warren","year":"2013","unstructured":"Warren KE, Poussaint TY, Vezina G et al (2013) Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working group. Pediatr Blood Cancer 60:1397\u20131401. doi:\n                    10.1002\/pbc.24562","journal-title":"Pediatr Blood Cancer"},{"key":"1724_CR26","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0025-6196(12)65470-6","volume":"62","author":"PJ Kelly","year":"1987","unstructured":"Kelly PJ, Daumas-Duport C, Scheithauer BW et al (1987) Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 62:450\u2013459","journal-title":"Mayo Clin Proc"},{"key":"1724_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1148\/radiol.2321030653","volume":"232","author":"S Lu","year":"2004","unstructured":"Lu S, Ahn D, Johnson G et al (2004) Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration index. Radiology 232:221\u2013228. doi:\n                    10.1148\/radiol.2321030653","journal-title":"Radiology"},{"key":"1724_CR28","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/jmri.20335","volume":"21","author":"J Oh","year":"2005","unstructured":"Oh J, Cha S, Aiken AH et al (2005) Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema. J Magn Reson Imaging JMRI 21:701\u2013708. doi:\n                    10.1002\/jmri.20335","journal-title":"J Magn Reson Imaging JMRI"},{"key":"1724_CR29","first-page":"2170","volume":"26","author":"BA Cohen","year":"2005","unstructured":"Cohen BA, Knopp EA, Rusinek H et al (2005) Assessing global invasion of newly diagnosed glial tumors with whole-brain proton MR spectroscopy. AJNR Am J Neuroradiol 26:2170\u20132177","journal-title":"AJNR Am J Neuroradiol"},{"key":"1724_CR30","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.ijrobp.2012.01.032","volume":"84","author":"EA Steffen-Smith","year":"2012","unstructured":"Steffen-Smith EA, Venzon DJ, Bent RS et al (2012) Single- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys 84:774\u2013779. doi:\n                    10.1016\/j.ijrobp.2012.01.032","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1724_CR31","first-page":"1989","volume":"24","author":"M Law","year":"2003","unstructured":"Law M, Yang S, Wang H et al (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24:1989\u20131998","journal-title":"AJNR Am J Neuroradiol"},{"key":"1724_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijrobp.2004.09.027","volume":"62","author":"A Laprie","year":"2005","unstructured":"Laprie A, Pirzkall A, Haas-Kogan DA et al (2005) Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy. Int J Radiat Oncol Biol Phys 62:20\u201331. doi:\n                    10.1016\/j.ijrobp.2004.09.027","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1724_CR33","doi-asserted-by":"crossref","unstructured":"Poussaint TY, Vajapeyam S, Ricci KI, et al. (2015) Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium. Neuro Oncol","DOI":"10.1093\/neuonc\/nov256"}],"container-title":["Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-016-1724-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00234-016-1724-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-016-1724-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T10:32:24Z","timestamp":1589625144000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00234-016-1724-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,20]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["1724"],"URL":"https:\/\/doi.org\/10.1007\/s00234-016-1724-8","relation":{},"ISSN":["0028-3940","1432-1920"],"issn-type":[{"value":"0028-3940","type":"print"},{"value":"1432-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,20]]},"assertion":[{"value":"30 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We declare that all human studies have been approved by the local ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. We declare that all patients gave informed consent prior to inclusion in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"AB received partial financial support from AstraZeneca to conduct this clinical trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}